Skip to main content

Amgen Australia Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

3 result(s) found, displaying 1 to 3
  • Wezlana (ustekinumab) has been approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
  • TGA Decision: Lumakras (sotorasib) is approved to treat adult patients with non-small cell lung cancer (NSCLC).
  • Australian prescription medicine decision summary

Help us improve this page